20(R)-Ginsenoside Rg3 protects SH-SY5Y cells against apoptosis induced by oxygen and glucose deprivation/reperfusion

Bioorg Med Chem Lett. 2017 Aug 15;27(16):3867-3871. doi: 10.1016/j.bmcl.2017.06.045. Epub 2017 Jun 19.

Abstract

As shown in our previous studies, 20(R)-ginsenoside Rg3 [20(R)-Rg3] exerts a neuroprotective effect on a rat model of transient focal cerebral ischemia, and the mechanism through which it decreases the mRNA expression of calpain I and caspase-3 has been delineated. However, researchers do not know whether 20(R)-Rg3 exhibits a neuroprotective effect following oxygen-glucose deprivation and reperfusion (OGD/R) injury in vitro. In the present study, 20(R)-Rg3 increased cell viability, decreased the LDH leakage rate, and inhibited the apoptosis rate in a concentration-dependent manner. In addition, 20(R)-Rg3 markedly decreased cleaved caspase-3 protein expression. Furthermore, 20(R)-Rg3 significantly decreased the Bax mRNA and protein levels and increased the levels of Bcl-2 mRNA and protein, subsequently decreasing the Bax/Bcl-2 protein ratio. Based on these findings, 20(R)-Rg3 exerts a neuroprotective effect against OGD/R-induced apoptosis.

Keywords: 20(R)-Ginsenoside Rg3; Apoptosis; Bax; Bcl-2; Oxygen-glucose deprivation/reperfusion.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / drug effects*
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Dose-Response Relationship, Drug
  • Ginsenosides / chemistry
  • Ginsenosides / pharmacology*
  • Glucose / metabolism*
  • Humans
  • Molecular Structure
  • Oxygen / metabolism*
  • Structure-Activity Relationship

Substances

  • Ginsenosides
  • ginsenoside Rg3
  • Glucose
  • Oxygen